"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

TapImmune and Marker Therapeutics Announce Entry into Merger Agreement

JACKSONVILLE, FL. –  TapImmune Inc. announced that it has entered into a definitive merger agreement to acquire Marker Therapeutics, Inc. (“Marker”), a privately-held clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

read more

Registration Open for SEBIO 2018!!

Celebrating its 20th Anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects.

read more

Apply to Present!!

Introduce your company to targeted investors, VC’s, and potential partners at the 2018 Southeast BIO Investor & Partnering Forum.

The Forum provides opportunities for both early and mid- to late stage companies that are looking for investment and business partners. Learn more about applying.

read more